Acetyl‐L‐carnitine for patients with hepatic encephalopathy

Source:
Cochrane Database of Systematic Reviews
Publisher:
Cochrane Database of Systematic Reviews
Publication date:
05 January 2019

Abstract

Review identified heterogeneous group of 5 trials (n=398) at high risk of bias and of random errors conducted by 1 research team assessing use in covert and overt hepatic encephalopathy.No data were found on mortality, serious adverse events, or days of hospitalisation v. placebo